CoreCap Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.33K Buy
211
+94
+80% +$2.15K ﹤0.01% 2317
2026
Q1
$2.58K Sell
117
-7
-6% -$122 ﹤0.01% 2346
2025
Q4
$1.46K Sell
124
-1,327
-91% -$17K ﹤0.01% 2532
2025
Q3
$23K Buy
1,451
+1,154
+389% +$16.7K ﹤0.01% 1619
2025
Q2
$3.4K Buy
297
+11
+4% +$124 ﹤0.01% 2207
2025
Q1
$3.87K Buy
286
+6
+2% +$100 ﹤0.01% 2166
2024
Q4
$4.73K Sell
280
-172
-38% -$3.35K ﹤0.01% 1986
2024
Q3
$9.19K Buy
+452
New +$9.24K ﹤0.01% 1817
2024
Q2
Sell
-358
Closed -$9.4K 1754
2024
Q1
$9.4K Buy
+358
New +$10.2K ﹤0.01% 1755
2022
Q4
$60K Buy
+1,960
New +$58.8K ﹤0.01% 927
2022
Q3
Sell
-1,986
Closed -$64K 764
2022
Q2
$64K Buy
+1,986
New +$73K 0.01% 856
2022
Q1
Sell
-2,678
Closed -$90K 778
2021
Q4
$90K Buy
+2,678
New +$83.4K 0.01% 788

Other funds holding CC

CoreCap Advisors's CC Position: Q2 2026 in Review

CoreCap Advisors increased its Chemours (CC) stake by 80% in Q2 2026, buying an estimated $2.15K and bringing the position to 211 shares worth $4.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

CoreCap Advisors first reported a position in CC in Q4 2021 and has held it in 12 quarters since. The position peaked at $90K in Q4 2021. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • CoreCap Advisors held 211 shares of Chemours worth $4.33K as of Q2 2026.
  • CoreCap Advisors bought 94 Chemours shares in Q2 2026, an estimated $2.15K.
  • Chemours made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2317 holding.
  • CoreCap Advisors first reported a position in Chemours in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's Chemours position peaked at $90K in Q4 2021.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.